Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCt Automotive Regulatory News (CTA)

Share Price Information for Ct Automotive (CTA)

Share Price is delayed by 15 minutes
Get Live Data
36.00    0.00 (0.00%)
Bid:
35.00
Ask:
37.00
Spread: 2.00 (5.714%)
Market Cap: £26.50m
CTA Live PriceLast checked at - London Stock Exchange

Intraday Ct Automotive Share Chart

Trading Update

14 Feb 2022 07:00

RNS Number : 5006B
CT Automotive Group PLC
14 February 2022
 

14 February 2022

 

CT AUTOMOTIVE GROUP PLC

("CT Automotive" or the "Group")

 

FY 2021 TRADING UPDATE

 

Positive trading - well positioned as global vehicle production recovers

 

CT Automotive, a leading designer, developer and supplier of interior components to the global automotive industry, today provides an update on its financial performance for the year ended 31 December 2021 ("FY 2021"), following admission to trading on AIM on 23 December 2021.

 

Trading Performance

 

The Group performed ahead of expectations for the year, with a positive trading performance in spite of the ongoing disruption to vehicle production caused by a global shortage of semiconductors.

 

Revenue for FY 2021 is expected to be approximately $133 million, up 21% compared to 2020 ($110 million). This was driven by the early completion of some Engineering, Design and Development programmes in Q4, as well an improved performance in serial production. Group gross margins were moderately lower than expected as a result of lower production volumes in China in Q4, with the completion of some de-stocking also impacting production efficiency.

 

As a result of the improved trading performance, underlying EBIT for the year is expected to be slightly ahead of expectations.

 

Outlook

 

The Board continues to expect global vehicle production volumes to recover during 2022 and automotive supply chain issues to resolve fully in 2023. Whilst the recovery remains in the early stages, the Board is encouraged by resilient order volumes in the year to date. The Group has long-term agreements with its customers and is well positioned, with c.95 per cent. of anticipated revenue in 2022 and c.90 per cent. of anticipated revenue in 2023 expected to come from projects which are currently in production, or on which the Group has been chosen as the nominated supplier.

 

The Group continues to invest in new facilities in Mexico and expanding existing capacity in the Czech Republic in order to enable local production, with the Mexico plant on track to commence production in mid-2022.

 

Notice of Results

 

The Group expects to announce its full year results for the year ended 31 December 2021 in May 2022.

 

Scott McKenzie, Chief Executive Officer of CT Automotive, commented:

 

"We are pleased with our trading performance in 2021, which was achieved against a challenging global automotive backdrop. We remain well placed to build on our strong track record of growth, client relationships and manufacturing excellence as global semiconductor shortages ease and vehicle production volumes recover."

 

For further information, please contact:

 

CT Automotive via. Engine MHP

Simon Phillips, Executive Chairman

Scott McKenzie, Chief Executive Officer

David Wilkinson, Chief Financial Officer

 

Engine MHP (Financial PR) Tel: +44 (0)20 3100 8540

Tim Rowntree CTAutomotive@mhpc.com

Charlie Barker

Charlie Protheroe

 

Liberum (Nominated Adviser and Broker) Tel: +44 (0)20 3100 2000

Richard Lindley

Benjamin Cryer

Chris Whitaker

 

Notes to editors

 

CT Automotive is engaged in the design, development and manufacture of bespoke automotive interior finishes (for example dashboard panels and fascia finishes) and kinematic assemblies (for example air registers, arm rests, deployable cup holders and storage systems), as well as their associated tooling, for the world's leading automotive original equipment suppliers ("OEMs") and global Tier One manufacturers.

 

The Group is headquartered in the UK with a low-cost manufacturing footprint. Key production facilities are located in Shenzhen and Ganzhou, China complemented by additional manufacturing facilities in Turkey, the Czech Republic and the UK.

 

CT Automotive's operating model enables it to pursue a price leadership strategy, supplying high quality parts to customers at a lower overall landed cost than competitors. This has helped the Group build a high-quality roster of OEM end customers, both directly and via Tier One suppliers including Faurecia and Marelli. End customers include volume manufacturers, such as Nissan, and luxury car brands such as Bentley and Lamborghini. In addition, the Group supplies electric car manufacturers, including Lucid. It has also recently started working with e.Go Mobile, a German manufacturer which plans to launch a series of small electric vehicles for the budget end of the market.

 

The Group currently supplies component part types to over 45 different models for 17 OEMs and delivered over four million systems in the 12 months to 31 December 2020. Since its formation, the Group has been the only significant new entrant into the market, which is characterised by high barriers to entry.

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTSFWFWFEESELE
Date   Source Headline
4th May 20127:00 amRNSDirector/PDMR Shareholding
3rd May 20127:00 amRNSDirector/PDMR Shareholding
25th Apr 20124:22 pmRNS1st Quarter Results
24th Apr 20127:00 amRNSDefinitive Proxy
12th Apr 20127:00 amRNSDoc re Preliminary Proxy Statement
12th Apr 20127:00 amRNSDividend Declaration
12th Apr 20127:00 amRNSForm 3
11th Apr 20127:00 amRNSForm 4s
5th Apr 20127:00 amRNSForm 4s
4th Apr 20127:00 amRNSForm 4s
22nd Mar 20127:00 amRNSAnnual Information Update
22nd Mar 20127:00 amRNSAnnual Information Update
22nd Mar 20127:00 amRNSDirector/PDMR Shareholding
22nd Mar 20127:00 amRNSAnnual Information Update
22nd Mar 20127:00 amRNSDirector/PDMR Shareholding
21st Mar 20126:02 pmRNSSchedule 13Gs
21st Mar 20126:01 pmRNSForm 8-K Filings
21st Mar 20127:00 amRNS3rd Quarter Results
21st Mar 20127:00 amRNSDoc re Proxy Statements
21st Mar 20127:00 amRNSOffer Document Posted
21st Mar 20127:00 amRNSHalf-Yearly Report
21st Mar 20127:00 amRNS1st Quarter Results
21st Mar 20127:00 amRNSAnnual Financial Report
12th Mar 20127:00 amRNSDirectors/PDMR Shareholding
9th Mar 20127:00 amRNSForm 4s
22nd Feb 20127:00 amRNSForm 10-K
27th Jan 20127:00 amRNSFinal Results
14th Dec 20114:12 pmRNSDividend Declaration
24th Oct 20115:16 pmRNS3rd Quarter Results
13th Oct 20117:00 amRNSDividend Declaration
25th Jul 20117:00 amRNSHalf Yearly Report
9th Jun 20117:00 amRNSDividend Declaration
3rd May 20117:00 amRNS1st Quarter Results
15th Apr 20111:00 pmRNSDisposal
14th Apr 20117:00 amRNSDividend Declaration
27th Jan 20113:58 pmRNSFinal Results
4th Jan 20117:00 amRNSDividend Declaration
21st Oct 20103:07 pmRNS3rd Quarter Results
21st Oct 20103:07 pmRNS3rd Quarter Results
13th Oct 20105:34 pmRNSDividend Declaration
22nd Jul 20103:58 pmRNSHalf Yearly Report
9th Jun 20104:45 pmRNSDividend Declaration
26th Apr 20103:34 pmRNS1st Quarter Results
15th Apr 20107:00 amRNSDividend Declaration
27th Jan 20103:52 pmRNSFinal Results
9th Dec 20095:28 pmRNSDividend Declaration
20th Oct 20094:19 pmRNS3rd Quarter Results
14th Oct 20095:52 pmRNSDividend Declaration
21st Jul 20095:43 pmRNSHalf Yearly Report
11th Jun 20097:00 amRNSDividend Declaration

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.